Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches

Mycobacterium abscessus (Mab) is a rapidly growing species of multidrug-resistant nontuberculous mycobacteria that has emerged as a growing threat to individuals with cystic fibrosis and other pre-existing chronic lung diseases. Mab pulmonary infections are difficult, or sometimes impossible, to treat and result in accelerated lung function decline and premature death. There is therefore an urgent need to develop novel antibiotics with improved efficacy. tRNA (m1G37) methyltransferase (TrmD) is a promising target for novel antibiotics. It is essential in Mab and other mycobacteria, improving reading frame maintenance on the ribosome to prevent frameshift errors. In this work, a fragment-based approach was employed with the merging of two fragments bound to the active site, followed by structure-guided elaboration to design potent nanomolar inhibitors against Mab TrmD. Several of these compounds exhibit promising activity against mycobacterial species, including Mycobacterium tuberculosis and Mycobacterium leprae in addition to Mab, supporting the use of TrmD as a target for the development of antimycobacterial compounds.

[1]  C. Haworth,et al.  British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) , 2017, BMJ Open Respiratory Research.

[2]  R. Gibson,et al.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis , 2015, Thorax.

[3]  Ning Gao,et al.  Selective inhibitors of bacterial t-RNA-(N(1)G37) methyltransferase (TrmD) that demonstrate novel ordering of the lid domain. , 2013, Journal of medicinal chemistry.

[4]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[5]  P. Gilligan,et al.  Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  T. Blundell,et al.  Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification , 2019, bioRxiv.

[7]  Peter J. Diggle,et al.  Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis☆ , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  Ruben D. Garcia-Ordonez,et al.  N‐Arylsulfonyl Indolines as Retinoic Acid Receptor‐Related Orphan Receptor γ (RORγ) Agonists , 2016, ChemMedChem.

[9]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[10]  Axel T. Brunger,et al.  Model bias in macromolecular crystal structures , 1992 .

[11]  Philip R. Evans,et al.  How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.

[12]  M. Frenkel-Morgenstern,et al.  Maintenance of Protein Synthesis Reading Frame by EF-P and m1G37-tRNA , 2015, Nature Communications.

[13]  I. Cliffe,et al.  Efficient and Selective Demethylation of Heteroaryl Methyl Ethers in the Presence of Aryl Methyl Ethers , 2011 .

[14]  Joseph M. Watts,et al.  Insights into catalysis by a knotted TrmD tRNA methyltransferase. , 2003, Journal of molecular biology.

[15]  D. Scott,et al.  Fragment-based approaches in drug discovery and chemical biology. , 2012, Biochemistry.

[16]  Shigeyuki Yokoyama,et al.  Tertiary structure checkpoint at anticodon loop modification in tRNA functional maturation , 2009, Nature Structural &Molecular Biology.

[17]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[18]  K. Rhee,et al.  Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes. , 2013, Current topics in microbiology and immunology.

[19]  Hye-Jin Yoon,et al.  Crystal structure of tRNA(m1G37)methyltransferase: insights into tRNA recognition , 2003, The EMBO journal.

[20]  C. Robinson,et al.  Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry , 2007, Nature Protocols.

[21]  J. Prell,et al.  Protein Conformation and Supercharging with DMSO from Aqueous Solution , 2011, Journal of the American Society for Mass Spectrometry.

[22]  H. M. Hassaneen.  New Approach to 4‐ and 5‐Aminopyrazole Derivatives , 2007 .

[23]  David Fox,et al.  Increasing the structural coverage of tuberculosis drug targets. , 2015, Tuberculosis.

[24]  Philip R. Evans,et al.  An introduction to data reduction: space-group determination, scaling and intensity statistics , 2011, Acta crystallographica. Section D, Biological crystallography.

[25]  Howard Xu,et al.  A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus , 2002, Molecular microbiology.

[26]  Anders Poulsen,et al.  Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors. , 2019, ACS infectious diseases.

[27]  L. Morawska,et al.  Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium , 2016, Science.

[28]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[29]  S. Yokoyama,et al.  Structural basis for methyl-donor–dependent and sequence-specific binding to tRNA substrates by knotted methyltransferase TrmD , 2015, Proceedings of the National Academy of Sciences.

[30]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[31]  M. Whiteley,et al.  Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum , 2015, Proceedings of the National Academy of Sciences.

[32]  D. Chan,et al.  Insight into Protein Conformation and Subcharging by DMSO from Native Ion Mobility Mass Spectrometry , 2016 .

[33]  Clemens Vonrhein,et al.  Data processing and analysis with the autoPROC toolbox , 2011, Acta crystallographica. Section D, Biological crystallography.

[34]  S. French,et al.  On the treatment of negative intensity observations , 1978 .

[35]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[36]  S. Yokoyama,et al.  Trm5 and TrmD: Two Enzymes from Distinct Origins Catalyze the Identical tRNA Modification, m1G37 , 2017, Biomolecules.

[37]  T. Comery,et al.  Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789). , 2012, Journal of medicinal chemistry.

[38]  D. Seidel,et al.  Redox isomerization via azomethine ylide intermediates: N-alkyl indoles from indolines and aldehydes. , 2011, Organic letters.

[39]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[40]  V. Brabec,et al.  Design, Preparation, and Characterization of Zn and Cu Metallopeptides Based On Tetradentate Aminopyridine Ligands Showing Enhanced DNA Cleavage Activity. , 2015, Inorganic chemistry.

[41]  B. Gicquel,et al.  Mycobacterium abscessus: a new antibiotic nightmare. , 2012, The Journal of antimicrobial chemotherapy.